Compare KSPI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KSPI | PEN |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | Kazakhstan | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 12.2B |
| IPO Year | 2024 | 2015 |
| Metric | KSPI | PEN |
|---|---|---|
| Price | $83.99 | $313.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | $113.00 | ★ $332.40 |
| AVG Volume (30 Days) | 422.2K | ★ 441.4K |
| Earning Date | 02-23-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.36 | ★ 367.34 |
| EPS | ★ 10.48 | 4.14 |
| Revenue | ★ $6,665,289,776.00 | $1,333,798,000.00 |
| Revenue This Year | $48.89 | $16.77 |
| Revenue Next Year | $17.82 | $14.12 |
| P/E Ratio | ★ $8.03 | $76.40 |
| Revenue Growth | ★ 54.22 | 14.61 |
| 52 Week Low | $70.61 | $221.26 |
| 52 Week High | $111.45 | $321.38 |
| Indicator | KSPI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 70.76 | 59.37 |
| Support Level | $76.62 | $302.19 |
| Resistance Level | $79.44 | $320.42 |
| Average True Range (ATR) | 2.03 | 7.75 |
| MACD | 0.46 | -1.54 |
| Stochastic Oscillator | 92.32 | 62.42 |
Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.